Xponance’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Xponance's ACLS Position: Q2 2026 in Review
Xponance increased its Axcelis (ACLS) stake by 5.3% in Q2 2026, buying an estimated $23K and bringing the position to 3,095 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.
Xponance first reported a position in ACLS in Q1 2023 and has held it in 11 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Xponance held 3,095 shares of Axcelis worth $586K as of Q2 2026.
- Xponance bought 155 Axcelis shares in Q2 2026, an estimated $23K.
- Axcelis made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1030 holding.
- Xponance first reported a position in Axcelis in Q1 2023 and has held it in 11 quarters since.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.